Genetically modified organisms - Medicinal Products
The panel assesses environmental risks from using medicinal products that contain or consist of genetically modified organisms.
This is an ongoing assignment for the Norwegian Environment Agency and the Norwegian Medicines Agency.
Contact
How we assess risk
To assess risk means to evaluate how likely it is that a known hazard will cause harm. In addition, we must assess how serious the harm is.